Hi Everyone,
My name is Fiona, and I work as an Analyst at the National Drug Authority of Uganda. My background is in quality control of pharmaceutical products, with a particular focus on assay techniques using HPLC, GC, and UV spectrophotometry. Recently, I’ve been involved in an exciting new project focused on the detection and analysis of nitrosamine impurities using LC-MS/MS.
I’m looking forward to learning from all of you and sharing insights from my experiences as well!
Welcome to the Nitrosamines exchange Fiona… I have no doubt you will find very insightful the discussion here in the community. We recently have seen an increase in analytical testing discussion topics, which I encourage to participate. Also feel free to post questions to the community or include your insights in any of the ongoing discussions. Welcome!
Thank you @Naiffer_Host
Hi,
I’m Dr. Minesh Patel, Currently I’m working as ADL-Manager in Pharmaceutical company. I have 22 yrs of experience in pharmaceutical companies. Experience in analytical method validation and method transfer of Drug substances and Drug products. Happy to join this community.
Hallo everyone,
My name is Jitendra Nikwade, i am currently working as a Principal scientist in Analytical method development department at Centaur Pharamaceutical Pune, India.
I have about 14 years experience in method development for Finish drug Product for US,EU and ROW market. I’m interested in control strategies of nitrosamines using LC/MS analysis. I appreciate this community and having great opportunity to exchange information and opinion reagding nitrosamine and its control
Hi, this is Miya from Japanese air filter company Nippon Muki.
We manufacture NOx removal gasphase filter as countermeasure of Nitrosamine Impurity. We have been working this project one and half years.
I would like to get latest information through this comunity.
Additinaly, if anyone is interested in our NOx removal gasphase filter, please feel free to contact us!
Hello everyone,
My name is Sara Oliveros and I’m a development analyst who’s gonna be specializing in Nitrosamine contamination and doing risk analysis on them, working at a Pharmaceutical company in Colombia. Nice to meet everyone, I hope to learn lots of things here!
Thank you.
Hello everyone!
I’m Purvaa Ingale, a M.pharm Pharmaceutics student studying at Manipal College of Pharmaceutical Sciences Udupi, India, currently in my 2nd year with an ongoing internship at Mylan (A Viatris Company) and my dissertation topic is Nitrosamines.
This is a great platform to learn and understand nitrosamines inside out. I’m delighted to be a part of this community and hoping to be in touch with you all regarding all the wonderful insights!
Hello All,
I am Ken Strassburger and I am excited to belong to this group. I have 25+ years experience in GC/MS and LC/MS using Ion Traps, Single Quads and QQQ instruments in natural product and pharmaceutical applications. I have developed numerous methods to cover the volatile nitrosamines NDMA and EDTA as well as SDSRi’s of propranolol, bisoprolol and diphenhydramine. I am especially interested in the use of high ph mobile phases in the analysis of SDSRi compounds by MRM methods and Bio-Relevant Studies of nitrosamine formation in the human gastric tract.
Hi; every one !!!
This is Dr. Pushpalata Sarjekar. Currently working with Pharmaceutical company. Deals with the risk assessments including Nitrosamine impurities.
This forum is one of the best forum for the enhancement of the technical updating and the Discussion as well.
Hi everyone,
I’m Emir Özçelik, a Quality Assurance Specialist in the pharmaceutical industry. I’m involved in supplier qualification, quality systems, and ensuring compliance with regulatory requirements.
I have been actively working on nitrosamine risk assessment for our products.
I’m happy to be here and look forward to learning from this community.
Hi everyone! I’m a new host from GxP center of Uzbekistan.
What motivated me most for joining this group is the opportunity to be part of a community where knowledge, experience, and ideas are actively shared.
Hi, I am Dr. Ganesh. I have strong expertise in structural elucidation and conformational analysis of unknown molecules. Since 2019, I have been actively working on nitrosamines and have extensive experience in method development using LC-MS and GC-MS techniques. I am interested in updating my knowledge on the latest regulatory trends, guidelines, and developments related to NDSRIs.
Hello everyone, my name is Irfan Ahmad. I hold a PhD in Chemical Engineering and work as a Development Scientist at Catalent. My role involves supporting drug product development and evaluating nitrosamine risk assessments for new client programs, including providing technical recommendations related to nitrosamine control and mitigation.
Hi everyone,
my name is Kristina and I work in pharmaceutical development, focusing on new generic formulations and on addressing nitrosamine impurities in existing products.
I joined this blog because I’ve seen that it brings together scientists from all over the world to discuss nitrosamines — a topic that has become increasingly important in the pharmaceutical industry.
I’m hoping to deepen my knowledge in this area, but also to share my own experience and learn from others along the way.